Dr. Neelam Kedia

Dr. Neelam Kedia is an experienced professional in the field of life sciences and biotechnology, currently serving as the Analytics Manager at MedTherapy Biotech since June 2024, focusing on assay development and qualification. Previously, Dr. Kedia held the position of Specialist in Process Development at Immuneel Therapeutics Private Limited from June 2022 to April 2024, where responsibilities included the development of CAR-T cell manufacturing processes. Prior to that, Dr. Kedia worked as a Research Scientist at Intas Pharmaceuticals, contributing to the development of Anti CD19 CAR-T Therapy and securing a significant grant for product development. Dr. Kedia's academic background includes a Ph.D. in Life Sciences from ICMR - National Institute for Research in Reproductive Health, along with multiple fellowships and degrees, highlighting a strong foundation in research and project development within the context of molecular and cellular biology.